Abstract
The disorders of movement produced by cerebellar disease are complex (Holmes, 1939). They include dysmetria, dysdiadochokinesis and decomposition of movement as well as intention tremor. The combination is disabling, and clinical descriptions of patients with cerebellar disorders often do not distinguish between the various modalities, but content themselves with describing the whole disability as cerebellar ataxia. Observations of improvement with treatment often use the same approach, assessing the patient’s competence on a number of motor tasks and recording the performance in terms of the time taken to complete them. This is a valid means of assessing function, for it uses as a yardstick tasks similar to those that the patient has to carry out from day to day. It is not helpful, however, to an understanding of the pharmacology of an individual item such as tremor (see Fahn, this volume, chapter 5). Thus a review of the treatment of cerebellar tremor cannot be strictly that: it is a review of the treatment of cerebellar disorders, in which tremor plays a prominent but not a solo role.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbeau, A. (1978). Emerging treatments: replacement therapy with choline or lecithin in neurological diseases. Can. J. Neurol. Sci., 5, 157–60.
Barbeau, A., Butterworth, R. F., Ngo, T., Breton, G., Melancon, S., Shapcott, D., Geoffroy, G. and Lernieux, B. (1976). Pyruvate metabolism in Friedreich’s ataxia. Can. J. Neurol. Sci., 3, 379–88.
Basmajian, J. V., Kukula, C. G., Nabrayan, M. G. and Takebe, K. (1975). Biofeedback treatment of footdrop after stroke compared with standard rehabilitation technique: effects on voluntary control and strength. Arch. Phys. Med. Rehabil., 56, 231–6.
Bird, E. D. and Iversen, L. L. (1974). Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain, 97, 457–72.
Braham, J., Sadeh, M., Turgman, J. and Sarova-Pinchas, I. (1979). Beneficial effect of propranolol in familial ataxia. Ann. Neurol., 5, 207.
Brice, J. and McLellan, L. (1980). Suppression of intention tremor by contingent deep-brain stimulation. Lancet, 1, 1221–2.
Brudny, J., Korein, J., Levidow, L., Grynbaum, B. B., Lieberman, A. and Friedmann, L. W. (1974). Sensory feedback therapy as a modality of treatment in central nervous system disorders of voluntary movements. Neurology, 24, 925–32.
Chase, R. A., Cullen, J. K., Sullivan, S. A. and Ommaya, A. K. (1965). Modification of intention tremor in man. Nature, 206, 485–7.
Cohen, E. L. and Wurtman, R. J. (1976). Brain acetylcholine: control by dietary choline. Science, 191, 561–2.
Crepel, F. and Dhanjal, S. S. (1982). Cholinergic mechanisms. Neurotransmission in the cerebellum of the rat. An in vitro study. Brain Res., 244, 59–68.
Davis, A. E. and Lee, R. G. (1980). EMG biofeedback in patients with motor disorders: an aid for coordinating activity in antagonistic muscle groups. Can. J. Neurol. Sci., 7, 199–206.
Davis, K. L., Berger, P. A. and Hollister, L. E. (1975). Choline for chronic tardive dyskinesia. New Engl. J. Med., 293, 152.
Davis, K. L., Hollister, L. E., Barchas, J. D. and Berger, P. A. (1976). Choline in tardive dyskinesia and Huntington’s disease. Life Sci., 19, 1507–16.
Duvoisin, R. C. (1967). Cholinergic-anticholinergic antagonism in parkinsonism. Arch. Neurol., 17, 124–6.
Eckernas, S. A. and Aquilonius, S. M. (1977). A simple radio-enzymatic procedure for the determination of choline and acetylcholine in the brain regions of rats sacrificed by microwave irradiation. Acta Physiol. Scand., 100, 446–51.
Growdon, J. H., Hirsch, M. J., Wurtman, R. J. and Wiener, W. (1977). Oral choline administration to patients with tardive dyskinesia. New Engl. J. Med., 297, 524–7.
Hewer, R. L., Cooper, R. and Morgan, M. H. (1972). An investigation into the value of treating intention tremor by weighting the affected limb. Brain, 95, 579–90.
Holmes, G. (1939). The cerebellum of man. Brain, 62, 1–30.
Kark, R. A. P., Blass, J. P. and Engel, W. K. (1974). Pyruvate metabolism in neuromuscular diseases. Evidence of a genetic defect in two families with the syndrome of Friedreich’s ataxia. Neurology (Minneap.), 24, 964–71.
Kark, R. A. P., Blass, J. P. and Spence, M. A. (1977). Physostigmine in familial ataxias. Neurology, 27, 70–2.
Klawans, H. C. and Rubovits, R. (1972). Central cholinergic-anticholinergic antagonism in Huntington’s chorea. Neurology (Minneap.), 22, 107–16.
Lawrence, C. M., Millac, P., Stout, G. S. and Ward, J. W. (1980). The use of choline chloride in ataxic disorders. J. Neurol. Neurosurg. Psychiatr., 43, 452–54.
Legg, N. J. (1978). Oral choline in cerebellar ataxia. Br. Med. J., 2, 1403–4.
Legg, N. J. (1979). Oral choline in cerebellar ataxia. Br. Med. J., 2, 133.
Livingstone, I. R., Mastaglia, F. L., Pennington, R. J. T. and Skilbeck, C. (1981). Choline chloride in the treatment of cerebellar and spinocerebellar ataxia. J. Neurol. Sci., 50, 161–74.
Manyam, B. V., Katz, L., Hare, T. A., Kaniefski, K. and Tremblay, R. D. (1981). Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington’s disease. Ann. Neurol., 10, 35–7.
Mariani, J. and Delahaye-Bouchaud, N. (1978). Effect of diazepam on the spontaneous and harmaline-induced electrical activity of Purkinje cells in the cerebellum of the rat and rabbit. Neuropharmacology, 17, 45–51.
Muramoto, O., Ando, K. and Kanazawa, I. (1982). Central noradrenaline metabolism in cerebellar ataxic mice. Brain Res., 237, 387–95.
Ogawa, N., Kuroda, H., Ota, Z., Yamamoto, M. and Otsuki, S. (1982). Cerebrospinal fluid γ-aminobutyric acid variations in cerebellar ataxia. Lancet, 2, 215.
Perry, T. L., Hansen, S. and Khoster, M. (1973). Huntington’s chorea: deficiency of γ-aminobutyric acid in brain. New Engl. J. Med., 288, 337–42.
Perry, T. L., Wright, J. M., Hansen, S. and MacLeod, P. M. (1979). Isoniazid therapy of Huntington’s disease. Neurology, 29, 370–5.
Perry, T. L., Wright, J. M., Hansen, S., Thomas, S. M. B., Allan, B. M., Baird, P. A. and Diewold, P. A. (1982). A double-blind clinical trial of isoniazid in Huntington’s disease. Neurology, 32, 354–8.
Philcox, D. V. and Kies, B. (1979). Choline in hereditary ataxia. Brain, 98, 309.
Rascol, A., Clanet, M., Montastruc, J. L., Delage, W. and Guiraud-Chaumeil, B. (1981). L5H tryptophan in the cerebellar syndrome treatment. Biomedicine, 35, 112–13.
Rosen, M. J., Dunfee, D. E. and Adelstein, B. D. (1979). Suppression of abnormal intention tremor by application of viscous damping. Proc. 4th Congr. Int. Soc. Electrophysiology and Kinesthesiology, Boston.
Sabra, A. F., Hallett, M., Sudarsky, L. and Mullally, W. (1982). Treatment of action tremor in multiple sclerosis with isoniazid. Neurology, 32, 912–13.
Sehested, P., Lund, H. I. and Kristensen, O. (1980). Oral choline in cerebellar ataxia. Acta Neurol. Scand., 62, 124–6.
Shoulson, I., Chase, T. N., Roberts, E. and van, Balgooy, J. N. A. (1975). Huntington’s disease-treatment with cinidazole-4-acetic acid. New Engl. J. Med., 293, 504–5.
Somerville, E. R. and Olanow, C. W. (1982). Valproic acid. Treatment of myoclonus in dyssynergia cerebellaris myoclonica. Arch. Neurol., 39, 527–8.
Tarsy, D., Leopold, N. and Sax, D. S. (1974). Physostigmine in choreiform movement disorders. Neurology (Minneap.), 24, 28–33.
Woodward, W. R., Blank, N. K. and Seil, F. J. (1982). Choline acetyltransferase activity in mouse cerebellar cultures. Brain Res., 241, 323–7.
Editor information
Editors and Affiliations
Copyright information
© 1984 N. J. Legg
About this chapter
Cite this chapter
Legg, N.J. (1984). Treatment of cerebellar tremor. In: Findley, L.J., Capildeo, R. (eds) Movement Disorders: Tremor. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06757-2_28
Download citation
DOI: https://doi.org/10.1007/978-1-349-06757-2_28
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-06759-6
Online ISBN: 978-1-349-06757-2
eBook Packages: MedicineMedicine (R0)